Axogen, Inc. (AXGN) is in Healthcare, Medical Devices, based in United States, listed on NasdaqCM. Market cap 2.12B USD. 52-week range 15.27 to 52.91 USD. Data as of 2026-10-09.
Axogen, Inc., together with its subsidiaries, engages in the development and commercialization of the technologies used for peripheral nerve regeneration and repair worldwide. The company offers Avance Nerve Graft, a processed nerve allograft intended for the surgical repair of peripheral nerve discontinuities; Axoguard Nerve Connector, a coaptation aid used to align and connect severed peripheral nerve ends in a tensionless repair; and Axoguard Nerve Protector, a product used to protect and ...